Milestone Scientific, Inc. (MLSS): Price and Financial Metrics
GET POWR RATINGS... FREE!
MLSS Stock Summary
- MLSS has a market capitalization of $43,273,105 -- more than approximately merely 12.57% of US stocks.
- For MLSS, its debt to operating expenses ratio is greater than that reported by only 9.09% of US equities we're observing.
- MLSS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 16.87% of US stocks.
- Stocks that are quantitatively similar to MLSS, based on their financial statements, market capitalization, and price volatility, are APYX, XXII, CXDO, STIM, and HNST.
- Visit MLSS's SEC page to see the company's official filings. To visit the company's web site, go to www.milestonescientific.com.
MLSS Valuation Summary
- MLSS's price/sales ratio is 5; this is 0% higher than that of the median Healthcare stock.
- MLSS's price/sales ratio has moved up 4.1 over the prior 243 months.
Below are key valuation metrics over time for MLSS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MLSS | 2022-12-02 | 5.0 | 4.2 | -6.0 | -4.9 |
| MLSS | 2022-12-01 | 4.4 | 3.6 | -5.2 | -4.1 |
| MLSS | 2022-11-30 | 4.2 | 3.4 | -5.0 | -3.8 |
| MLSS | 2022-11-29 | 4.6 | 3.8 | -5.5 | -4.3 |
| MLSS | 2022-11-28 | 4.5 | 3.7 | -5.4 | -4.2 |
| MLSS | 2022-11-25 | 4.5 | 3.7 | -5.4 | -4.2 |
MLSS Growth Metrics
- Its 3 year net income to common stockholders growth rate is now at -22.22%.
- Its 2 year price growth rate is now at -48.44%.
- Its year over year cash and equivalents growth rate is now at -21.8%.
The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 9.411002 | -3.221857 | -7.85378 |
| 2022-06-30 | 9.303536 | -4.135996 | -7.925184 |
| 2022-03-31 | 10.08091 | -4.557275 | -7.747171 |
| 2021-12-31 | 10.30471 | -4.017581 | -6.818317 |
| 2021-09-30 | 9.670744 | -6.376852 | -6.776149 |
| 2021-06-30 | 8.808621 | -6.556074 | -6.223931 |
MLSS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
- MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
- TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.
The table below shows MLSS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.423 | 0.616 | -2.177 |
| 2021-03-31 | 0.315 | 0.637 | -2.538 |
| 2020-12-31 | 0.325 | 0.666 | -3.651 |
| 2020-09-30 | 0.411 | 0.683 | -7.765 |
| 2020-06-30 | 0.616 | 0.698 | 30.088 |
| 2020-03-31 | 1.274 | 0.690 | 6.927 |
MLSS Stock Price Chart Interactive Chart >
MLSS Price/Volume Stats
| Current price | $0.62 | 52-week high | $2.25 |
| Prev. close | $0.68 | 52-week low | $0.55 |
| Day low | $0.62 | Volume | 25,500 |
| Day high | $0.68 | Avg. volume | 105,686 |
| 50-day MA | $0.70 | Dividend yield | N/A |
| 200-day MA | $0.98 | Market Cap | 42.74M |
Milestone Scientific, Inc. (MLSS) Company Bio
Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.
Latest MLSS News From Around the Web
Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.
Maxim Group Sticks to Their Buy Rating for Milestone Scientific (MLSS)Maxim Group analyst Anthony Vendetti maintained a Buy rating on Milestone Scientific (MLSS - Research Report) yesterday and set a price target of $4.00. The company's shares closed yesterday at $0.68.Vendetti covers the Healthcare sector, focusing on stocks such as Pulse Biosciences, ReShape Lifesciences, and Venus Concept. According to TipRanks, Vendetti has an average return of -4.6% and a 32.40% success rate on recommended stocks. Milestone Scientific has an analyst consensus of Moderate Buy, with a price target consensus of $4.00.See the top stocks recommended by analysts >>Based on Milestone Scientific's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $1. |
Milestone Scientific Achieves Revenue of $2.2 Million for the Third Quarter of 2022Reports 34.4% sequential increase in sales over the second quarter of 2022ROSELAND, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended September 30, 2022. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “I am pleased to report we achieved both sequen |
Milestone Scientific Schedules Third Quarter 2022 Financial Results and Business Update Conference CallROSELAND, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 15, 2022, to discuss the company’s financial results for the third quarter ended September 30, 2022, as well as the company’s corporate progress and other developments. The conference call will be availabl |
Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12thMilestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois. |
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL HealthROSELAND, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful evaluation, it has commenced sales of its CompuFlo® Epidural disposables to UofL Health (University of Louisville), a leading academic health system based in Louisville, Kentucky. UofL Health owns and operates six hospitals and four medical centers, providin |
MLSS Price Returns
| 1-mo | -7.53% |
| 3-mo | -28.74% |
| 6-mo | -36.55% |
| 1-year | -67.37% |
| 3-year | -59.48% |
| 5-year | -40.95% |
| YTD | -69.90% |
| 2021 | -2.83% |
| 2020 | 52.52% |
| 2019 | 318.67% |
| 2018 | -71.86% |
| 2017 | -15.71% |
Continue Researching MLSS
Want to do more research on Milestone Scientific Inc's stock and its price? Try the links below:Milestone Scientific Inc (MLSS) Stock Price | Nasdaq
Milestone Scientific Inc (MLSS) Stock Quote, History and News - Yahoo Finance
Milestone Scientific Inc (MLSS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...